Genmab A/S vs Vertex Pharmaceuticals
GMAB and VRTX side by side, both in drugs. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How GMAB and VRTX compare
Vertex Pharmaceuticals scores higher on the StockData Score (15 against 0 for Genmab A/S), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | GMAB | VRTX |
|---|---|---|
| Size and price | ||
| Market cap | – | $142B |
| Share price | $57.06 | $558.88 |
| Change, 1 year | 97.1% | 34.0% |
| Change, 5 years | 22.8% | 190% |
| Beta (5Y) | 0.78 | 0.54 |
| Employees | 3,029 | 600K |
| StockData Score | ||
| Total score | 0 | 15 (better) |
| Valuation score | 0 | 0 |
| Growth score | 0 | 3 (better) |
| Performance score | 0 | 6 (better) |
| Health score | 0 | 6 (better) |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/E | – | 32.5× |
| P/S | – | 11.3× |
| P/B | – | 7.0× |
| EV/EBITDA | – | 26.8× |
| P/FCF | – | 37.3× |
| PEG | – | 5.32 |
| FCF yield | – | 2.7% |
| Fair value | – | $407.96 |
| Margin of safety | – | −37.0% |
| Growth | ||
| Revenue growth (TTM) | – | 10.2% |
| Revenue growth, 5Y average | – | 14.1% |
| Net income growth (TTM) | – | 21.1% |
| EPS growth (TTM) | – | 22.4% |
| EPS growth, 5Y average | – | 8.3% |
| Profitability | ||
| Gross margin | – | 86.0% |
| Operating margin | – | 38.0% |
| Net margin | – | 35.0% |
| FCF margin | – | 30.2% |
| Return on equity | – | 23.5% |
| Return on invested capital | – | 34.4% |
| Financial health | ||
| Debt / equity | – | 0.00 |
| Current ratio | – | 3.19 |
| Altman Z-score | – | 14.06 |
| Piotroski F-score | – | 7 |
| Dividends and buybacks | ||
| Buyback yield | – | 1.4% |
| Shareholder yield | – | 1.4% |
| Ownership | ||
| Held by institutions | 79.5% | 95.6% |
| Held by insiders | 0.00% | 0.23% |
| Insider net buying, 12 months | – | −$158M |
| Superinvestors holding | – | 1 |
| Short interest, % of float | – | 1.8% |
Go deeper
- GMAB stock overview
- GMAB income statement
- GMAB valuation and score
- VRTX stock overview
- VRTX income statement
- VRTX valuation and score
Other comparisons
For information only, not investment advice. Check the source filings before relying on any figure.